Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: HemaNiche Biotech Co., Ltd
January 13, 2026
HemaNiche Biotech Co., Ltd
Orphan Drug Designation
treatment of post-hematopoietic stem cell transplantation thrombocytopenia
Disease Area:
Rare Disease
Source
Scroll to Top